Members of the Food and Drug Administration Advisory Panel are expected to meet again on Friday to discuss whether a “mix-and-match” dose of the Covid-1 vaccine should be approved.
The panel, which approved a low-dose modern booster for a specific population on Thursday, will consider a one-dose Johnson & Johnson booster shot.
It is unknown at this time what he will do after leaving the post. Approximately, 000,000 people were studied after receiving a second dose two months after their first dose, and only 117 people were tracked after taking a second shot at six months.
The panel will also consider whether those who initially received J&J one-dose shots should receive additional doses of Pfizer or Modern shots. A national health institute published this week suggested that the best booster for J&J recipients could be one of the other two manufacturers. Studies have shown that more than two doses of J&J are provided by a booster from another manufacturer after a J&J shot.
An additional dose of Pfizer has already been approved for older adults, adults with underlying conditions, and those who work in high-risk environments. According to the CDC, 5.3% of American adults received a booster dose of their COVID vaccine.
Also in the news:
– Strict vaccine requirements for all Italian workers have been in effect since Friday. This rule requires all employees to show a health pass to enter their place of employment. Police were enforceable because the protests were expected against the rules and could take violent forms.
More than 100 workers at the Los Los Alamos National Laboratory, the nuclear lab where the atomic bomb was made, are suing for a vaccine mandate that gives them until Friday to be vaccinated or expelled.
The office of Inn Finnish President Sauli Ninstore says he is isolating himself as a precaution after coming in contact with the coronavirus after a meeting with a Latvian colleague in Sweden.
Anyone aged 12 or older must provide proof of COVID-19 vaccine or recent negative test to participate in a major event in Washington state from November 15.
Sen of the state of Las Alaska.
📈 Today’s numbers are numbers According to Johns Hopkins University data, more than 44.7 million confirmed Covid-19 cases and more than 721,500 deaths have been recorded in the United States. Worldwide total: more than 239.5 million cases and 4.8 million deaths. According to the CDC, more than 188.2 million Americans – 56.7% of the population – have been fully vaccinated.
What we read: During the epidemic, some college football coaches cashed in despite coward-related cutbacks. Brian Goff, a professor of economics at Western Kentucky, said doing so has created a “misleading” discrepancy between “spending as usual” and “weak talk and penny-pitching” since the epidemic began.
Keep refreshing this page for the latest news. Want more? Sign up for USA TODAY’s Coronavirus Watch newsletter to receive updates directly in your inbox and join our Facebook group.
The FDA will call an independent panel on Mark’s Covid pill
The Food and Drug Administration said Thursday it will call in a panel of outside experts next month to review information on the safety and efficacy of Mark’s pill for the treatment of Covid-1 treat.
Although those panels were standard for reviewing vaccine data, the FDA has not yet formed a similar panel for the treatment of Covid-1 treatments.
“We believe that, in this case, a public discussion of this information with the agency’s advisory committee will help ensure a clear understanding of scientific data and information,” said Dr. Pat Patrizia Kavajoni, director of the FDA’s drug center.
The group will meet on November 30, which means Merck’s pills will probably not be approved until December.
Earlier this month, Mark said its test data showed the test drug had prevented half of the deadly coronavirus infections that would otherwise have sent people to the hospital.
‘Break up’ with J&J? Some are ready to use Pfizer or Modern
As an FDA panel considers Johnson & Johnson booster shots on Friday, a day after supporting low-dose modern booster, some recipients of the first J&J shots say they don’t necessarily want another dose of the company’s vaccine.
Jill Oliver, 56, a resident of Boulder, Colorado, said: “I’m going to sever ties with J&J. He was hesitant to get a company shot in March. Although he wanted to wait for a modern or Pfizer vaccine, he listened to public health leaders The first vaccine is available.
“I thought I was doing the right thing,” Oliver said. “Now, I’m walking around with my mask on and not feeling safe when I got on the plate and did what I was told.”
Studies have shown that while it remains highly effective in preventing serious illness and death, the J&J vaccine is less effective in preventing significant COVID infections than modern and Pfizer. And data from J&J boosters remains limited.
– Adriana Rodriguez
Florida Governor vows to challenge Biden’s Covid vaccine mandate
Florida will challenge the Biden administration’s vaccine mandate in federal court, Governor Ron de Santis said Thursday, requiring businesses and hospitals to stay pending “reduced.”
President Joe Biden’s order has not yet been released but is expected later this month. This applies to hospitals that treat Medicare and Medicaid patients and employers with 100 or more employees.
Some Florida hospitals already require the COVID-19 vaccine in anticipation of the upcoming federal administration.
“We’re going to compete with it immediately,” De Santis said Thursday at a Florida Department of Health office, where he linked the promotion of his monochromatic antibody treatment to recent statewide Covid hospital admissions. “And I think we’re going to lose the mandate in court. I also think we have a responsibility at the state level to do what we have to do to protect Floridians from the mandate so they can lose their jobs.”
Dissent, who has been adamant in his opposition to the vaccine requirement, cites unconfirmed statistics from monoclonal treatment centers, noting that a large percentage of those seeking treatment have already been vaccinated. USA Today Network – Florida filed a public record request more than a week ago for these figures. The Florida Department of Health did not create these.
-Frank Gluck, Fort Myers News-Press
Modern Booster is supported by the Advisory Panel for the Elderly, Risky
A federal advisory committee unanimously supports booster shots of the Modern Covid-1 vaccine for people 5 years of age or older, as well as certain medical conditions or jobs in young adults that increase their risk of infection. The booster will be half the regular dose, at least six months after the second shot.
If the panel’s decision is verified by a second advisory group and top officials from the Food and Administration Administration, the Modern Booster will be the second to be approved for emergency use. Pfizer-BioNTech additional shots were approved late last month.
– Karen Weintrab and Elizabeth Weiss, USA Today
Contributed by: Associated Press